Xos, Inc.

LOS ANGELES, CA · Founded 2021 · Medtech · Public

Elemental analysis instruments and X-ray optics systems

Claim this profile

Follows are private to you and power your alerts

Updated · xos.com

Sector
Medtech
Headquarters
LOS ANGELES, CA
Founded
2021
Latest Form D
$20M, Aug 2022
Total capital
$40M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$40M
2 Form D · last Aug 2022
50 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
4
2 pending · first 2019
Rank in peer group#31 of 160

Capital timeline

2022FEDERAL ↑EQUITY ↓Cumulative $40M1st Form D$20M2nd Form D$20M
2022FEDERAL ↑EQUITY ↓Cumulative $40M1st Form D$20M2nd Form D$20M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$20M
  • Private capital raisedForm D · SEC · 1st filing$20M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 160 peers

Line = median

Medtech · Instrument

  • Granted patents#31 · top 19%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Alice K. JacksonDirectorNamed in SEC Form D filings
  • Anousheh N. AnsariDirectorNamed in SEC Form D filings
  • Burt K. JordanDirectorNamed in SEC Form D filings
  • Dakota SemlerExecutive Officer, DirectorNamed in SEC Form D filings
  • Ed Sara RappDirectorNamed in SEC Form D filings
  • George N. MattsonDirectorNamed in SEC Form D filings
Show all 10 people
  • Giordano SordoniExecutive Officer, DirectorNamed in SEC Form D filings
  • Kingsley AfemikheExecutive OfficerNamed in SEC Form D filings
  • Robert FerberExecutive OfficerNamed in SEC Form D filings
  • S. Sara MathewDirectorNamed in SEC Form D filings

What it has protected

USPTO · 4 granted of 6
Show all 6 patent records
  • Zeta Surgical Inc.Similar federal contract value in Medtech · null in contracts
  • Eliaz Therapeutics, Inc.Similar federal contract value in Medtech · null in contracts
  • Magnendo Corp.Similar federal contract value in Medtech · null in contracts
  • ALLIED INNOVATIVE SYSTEMS, LLCSimilar federal contract value in Medtech · null in contracts
  • Heru, Inc.Similar federal contract value in Medtech · null in contracts
  • Summit Naturals Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .